Address
20 Park Plaza
Boston, MA 02116
United States of America (the)
Phone
617-744-4400
Website
Sector
Healthcare
Industry
Biotechnology
Employees
15
First IPO Date
May 23, 2008
| Name | Title | Pay | Year Born |
| John J. Alam | Co-Founder, Chief Executive Officer, President & Director | 952,940 | 1962 |
| Sylvie L. Gregoire | Co-Founder & Director | 40,000 | 1961 |
| Kelly Blackburn | Executive Vice President of Clinical Development | 609,939 | 1964 |
| William Robert Elder | Chief Financial Officer, General Counsel & Corporate Secretary | 643,664 | 1983 |
| Mark A. De Rosch | Executive Vice President of Regulatory, Government Affairs & Program Management | 0 | 1964 |
| Marinus Verwijs | Executive Vice President of Technical Operations | 0 | 1976 |
| Claudia Ordonez | Senior Vice President of Medical Science | 0 | 1966 |
| Matthew Winton | Chief Commercial & Business Officer | 0 | 1978 |
CervoMed Inc., headquartered in Boston, Massachusetts, operates as a clinical-stage biotechnology firm committed to discovering, developing, and ultimately bringing to market pharmaceutical solutions for various neurodegenerative conditions. A central component of their therapeutic pipeline is neflamapimod, an innovative small molecule designed for oral administration and capable of crossing the blood-brain barrier. This compound is currently being advanced as a potential treatment for debilitating ailments such as Lewy body dementia (DLB), Alzheimer's disease, and for aiding recovery following a cerebral stroke.